These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2967258)

  • 1. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
    van Hulsteijn H; Fibbe W; Bertina R; Briët E
    Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and coagulation factors in proliferative diabetic retinopathy.
    Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
    J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PF,VIII/vWF,B-TG and PF4 in diabetic subjects, both type 1 and 2, with and without retinopathy.
    Guastamacchia E; Di Paolo S; Santoro G; Damato A; Nardelli GM; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):499-505. PubMed ID: 2412573
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
    Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy.
    Brooks AM; Hussein S; Chesterman CN; Martin JF; Alford FP; Penington DG
    Thromb Haemost; 1983 Apr; 49(2):123-7. PubMed ID: 6223403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII, von Willebrand factor and platelet adhesiveness in diabetic retinopathy.
    Nozaki H; Hiramatsu K; Arimori S
    Tokai J Exp Clin Med; 1987 Mar; 12(1):7-9. PubMed ID: 3130682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.
    Coller BS; Frank RN; Milton RC; Gralnick HR
    Ann Intern Med; 1978 Mar; 88(3):311-6. PubMed ID: 305223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function in diabetic retinopathy: levels of beta-thromboglobulin and platelet factor 4.
    Fenández-Vigo J; Cordido M; Fernández Sabugal J; Cordido F
    Metab Pediatr Syst Ophthalmol (1985); 1992; 15(1-3):5-8. PubMed ID: 1484500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
    Burrows AW
    Horm Metab Res Suppl; 1981; 11():22-5. PubMed ID: 6172350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New methods in coagulation.
    Triplett DA
    Crit Rev Clin Lab Sci; 1981; 15(1):25-84. PubMed ID: 6459909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloprost reduces procoagulant activity in the extracorporeal circuit.
    Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
    J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease.
    van Oost BA; Veldhuyzen BF; van Houwelingen HC; Timmermans AP; Sixma JJ
    Thromb Haemost; 1982 Dec; 48(3):289-93. PubMed ID: 6187082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function in sickle cell disease during steady state.
    Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
    Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
    Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet hyperactivity in diabetic retinopathy: etiologic factor or epiphenomenon of microangiopathy?].
    García Pascual L; Simó R; Monasterio J; Soriano B; Ortega AM; Mesa J
    Rev Clin Esp; 1993 May; 192(9):420-3. PubMed ID: 8516505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.